Treating Onychomychosis
Primary Purpose
Onychomycosis
Status
Unknown status
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Noveon laser
Sponsored by
About this trial
This is an interventional treatment trial for Onychomycosis
Eligibility Criteria
Inclusion Criteria:
- 18 years or older
- positive onychomycosis
- negative pregnancy
Exclusion Criteria:
- peripheral neuropathy
Sites / Locations
- Nomir Medical
Outcomes
Primary Outcome Measures
Complete or near complete disappearance of toenail fungus
Secondary Outcome Measures
Full Information
NCT ID
NCT00776464
First Posted
October 18, 2008
Last Updated
October 20, 2008
Sponsor
Nomir Medical Technologies
1. Study Identification
Unique Protocol Identification Number
NCT00776464
Brief Title
Treating Onychomychosis
Study Type
Interventional
2. Study Status
Record Verification Date
October 2008
Overall Recruitment Status
Unknown status
Study Start Date
November 2008 (undefined)
Primary Completion Date
November 2009 (Anticipated)
Study Completion Date
January 2010 (Anticipated)
3. Sponsor/Collaborators
Name of the Sponsor
Nomir Medical Technologies
4. Oversight
5. Study Description
Brief Summary
A study to treat 4 toes at a time to eliminate Onychomycosis
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Onychomycosis
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2, Phase 3
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
60 (Anticipated)
8. Arms, Groups, and Interventions
Intervention Type
Device
Intervention Name(s)
Noveon laser
Intervention Description
Two wavelenghts of light
Primary Outcome Measure Information:
Title
Complete or near complete disappearance of toenail fungus
Time Frame
360 days
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
64 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
18 years or older
positive onychomycosis
negative pregnancy
Exclusion Criteria:
peripheral neuropathy
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Alan Robbins, MD
Phone
781-893-1000
Email
alanhrobbins@comcast.com
Facility Information:
Facility Name
Nomir Medical
City
Waltham
State/Province
Massachusetts
ZIP/Postal Code
02452
Country
United States
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Alan robbins, MD
Phone
781-893-1000
Email
alanrobbins@comcast.com
12. IPD Sharing Statement
Learn more about this trial
Treating Onychomychosis
We'll reach out to this number within 24 hrs